The estimated Net Worth of Leanne M Zumwalt is at least $9.86 Milhão dollars as of 18 September 2020. Ms. Zumwalt owns over 36,923 units of DaVita Inc stock worth over $5,747,369 and over the last 16 years she sold DVA stock worth over $299,495. In addition, she makes $3,811,700 as Group Vice President e Government Affairs at DaVita Inc.
Sign up
Ms. Zumwalt DVA stock SEC Form 4 insiders trading
LeAnne has made over 23 trades of the DaVita Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently she exercised 36,923 units of DVA stock worth $2,680,610 on 18 September 2020.
The largest trade she's ever made was exercising 44,000 units of DaVita Inc stock on 23 February 2016 worth over $1,907,400. On average, LeAnne trades about 5,712 units every 86 days since 2009. As of 18 September 2020 she still owns at least 37,323 units of DaVita Inc stock.
You can see the complete history of Ms. Zumwalt stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
LeAnne Zumwalt biography
LeAnne M. Zumwalt is no longer serves as Group Vice President, Government Affairs of the Company effective 1/31/2021. She has served as our Group Vice President, Government Affairs since July 2011, and from July 2011 to October 2019 also led our purchasing operations. From January 2000 to July 2011, Ms. Zumwalt served as our Vice President in many capacities. From January 2000 to October 2009, she served as our Vice President, Investor Relations while having other responsibilities. From 1997 to 1999, Ms. Zumwalt served as CFO of Vivra Specialty Partners, Inc. a privately held healthcare service and technology firm. From 1991 to 1997, Ms. Zumwalt held various executive positions, including CFO, at Vivra Incorporated, a publicly-held provider of renal dialysis services and other healthcare services. Prior to joining Vivra Incorporated, Ms. Zumwalt was a Senior Manager at Ernst & Young LLP. In March 2018, Ms. Zumwalt was appointed to the Board of Directors of ADPT Holdings, LLC, a privately held healthcare services company and successor in interest to Adeptus Health, Inc., which was a publicly traded company.
What is the salary of LeAnne Zumwalt?
As the Group Vice President e Government Affairs of DaVita Inc, the total compensation of LeAnne Zumwalt at DaVita Inc is $3,811,700. There are 5 executives at DaVita Inc getting paid more, with Javier Rodriguez having the highest compensation of $16,853,500.
How old is LeAnne Zumwalt?
LeAnne Zumwalt is 61, she's been the Group Vice President e Government Affairs of DaVita Inc since 2011. There are 3 older and 17 younger executives at DaVita Inc. The oldest executive at DaVita Inc is John Nehra, 71, who is the Independent Director.
What's LeAnne Zumwalt's mailing address?
Leanne's mailing address filed with the SEC is C/O AKEBIA THERAPEUTICS, INC., 245 FIRST ST., CAMBRIDGE, MA, 02142.
Insiders trading at DaVita Inc
Over the last 22 years, insiders at DaVita Inc have traded over $539,813,199 worth of DaVita Inc stock and bought 20,841,023 units worth $1,590,012,094 . The most active insiders traders include Hathaway Incbuffett Warren ..., R. Ted Weschler,, eKent J Thiry. On average, DaVita Inc executives and independent directors trade stock every 12 days with the average trade being worth of $12,626,872. The most recent stock trade was executed by Kathleen Alyce Waters on 28 August 2024, trading 26,333 units of DVA stock currently worth $1,999,991.
What does DaVita Inc do?
about davita kidney care davita kidney care is a division of davita healthcare partners inc., a fortune 500® company that, through its operating divisions, provides a variety of health care services to patient populations throughout the united states and abroad. a leading provider of dialysis services in the united states, davita kidney care treats patients with chronic kidney failure and end stage renal disease. davita kidney care strives to improve patients' quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. as of march 31, 2015, davita kidney care operated or provided administrative services at 2,197 outpatient dialysis centers located in the united states serving approximately 174,000 patients. the company also operated 93 outpatient dialysis centers located in 10 countries outside the united states. davita kidney care supports numerous programs dedicated to creating positive,
What does DaVita Inc's logo look like?
Complete history of Ms. Zumwalt stock trades at Akebia Therapeutics e DaVita Inc
DaVita Inc executives and stock owners
DaVita Inc executives and other stock owners filed with the SEC include:
-
Javier Rodriguez,
Chief Executive Officer, Director -
Joel Ackerman,
Chief Financial Officer, Treasurer -
Charles Berg,
Director -
Kathleen Waters,
Chief Legal Officer -
Javier J. Rodriguez,
CEO & Exec. Director -
LeAnne Zumwalt,
Group Vice President, Government Affairs -
Michael David Staffieri,
Chief Operating Officer of Kidney Care -
Joel Ackerman,
CFO & Treasurer -
Kathleen Alyce Waters,
Chief Legal and Public Affairs Officer -
James O. Hearty,
Chief Compliance Officer -
Barbara Desoer,
Independent Director -
Pascal Desroches,
Independent Director -
Pamela Arway,
Independent Chairman of the Board -
John Nehra,
Independent Director -
Paul Diaz,
Independent Director -
Phyllis Yale,
Independent Director -
Jim Gustafson,
Vice President - Investor Relations -
Paula Price,
Independent Director -
Shawn Guertin,
Director -
Kenny Gardner,
Chief People Officer - DaVita Kidney Care -
James Hearty,
Chief Compliance Officer -
John Winstel,
Chief Accounting Officer -
Kenneth Gardner Smith,
Chief People Officer -
Kenny Gardner,
Chief People Officer -
Atul Mathur,
Exec. VP of Global Operations -
Bill Myers,
VP of Marketing & Communications -
John D. Winstel,
Chief Accounting Officer -
Jeanine Marie Jiganti,
Chief Compliance Officer -
Peter T Grauer,
Director -
James K Hilger,
Vice President and Controller -
William L Roper,
Director -
Carol Anthony Davidson,
Director -
Roger Valine,
Director -
Joseph C Mello,
Chief Operations Officer -
Allen Nissenson,
Chief Medical Officer -
Dennis W Pullin,
Director -
R. Ted Weschler,,
-
Hathaway Incbuffett Warren ...,
-
Robert J Margolis,
Co-Chairman of the Board -
Laura Mildenberger,
SVP & Chief People Officer -
Kim M Rivera,
VP, Gen. Counsel & Secretary -
Dennis Kogod,
President - West -
Garry E Menzel,
Senior Vice President, Finance -
David T Shapiro,
Chief Compliance Officer -
Charles J Mcallister,
Chief Medical Officer -
Steven J Udicious,
V.P., Sec. and Gen. Counsel -
Joseph Schohl,
VP, Secretary & Gen. Counsel -
Willard Woodson Jr Brittain,
Director -
Nancy Ann Deparle,
Director -
Mary Kowenhoven,
Vice President - Strategy -
Thomas O Usilton,
Group Vice President -
Patricia Jones,
Chief People Officer -
C Raymond Jr Larkin,
Director -
Christopher J Riopelle,
Chief Compliance Officer -
Thomas L Kelly,
Executive Vice President -
Luis Borgen,
Chief Financial Officer -
Georgina Randolph,
Senior Vice President -
Richard B Fontaine,
Director -
Mark G Harrison,
Chief Financial Officer -
Richard K Whitney,
Chief Financial Officer -
Richard C Vaughan,
Director -
Gary Beil,
Vice President and Controller -
Patrick A Broderick,
VP, Secretary & Gen. Counsel -
Lori Richardson Pelliccioni,
Cheif Compliance Officer -
Michele J Hooper,
Director -
Michael David Staffieri,
Chief Operating Officer, DKC -
Kent J Thiry,
Executive Chairman -
Gregory J. Moore,
Director -
Jason M. Hollar,
Director -
Adam H Schechter,
Director -
Christopher Michael Berry,
Chief Accounting Officer -
Wendy Lee Schoppert,
Director